Navigation Links
FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
Date:5/21/2009

ter degree in SAMSCA-treated patients compared to placebo-treated patients as early as 8 hours after the first dose, and the change was maintained for 30 days. The percentage of patients requiring fluid restriction (defined as less than 1L/day at any time during the treatment period) was also significantly less (p less than 0.0017) in the SAMSCA-treated group (30/215, 14 percent) as compared with the placebo-treated group (51/206, 25 percent).

In an open-label study (SALTWATER), 111 patients, 94 of whom were hyponatremic, who had previously been treated with either placebo or SAMSCA (and who had returned to standard of care for at least 7 days), were administered SAMSCA. Upon initiation of therapy, average serum sodium concentrations increased to approximately the same levels as observed for those patients previously treated with SAMSCA and were sustained for at least a year.

The safety of SAMSCA has been evaluated in more than 4,000 patients, approximately 650 of which had hyponatremia. Of these 650 patients, approximately 219 received SAMSCA for six months or more. In the two 30-day, double-blind, placebo-controlled trials, the most common adverse reactions (greater than or equal to 5 percent more frequently than in patients receiving placebo) observed in patients receiving SAMSCA (n equals 223, placebo n equals 220) were thirst (16 percent vs. 5 percent in placebo patients), dry mouth (13 percent vs. 4 percent), asthenia (9 percent vs. 4 percent), constipation (7 percent vs. 2 percent), pollakiuria or polyuria (11 percent vs. 3 percent), and hyperglycemia (6 percent vs. 1 percent). In these studies, 10 percent of SAMSCA patients discontinued therapy due to adverse reactions compared to 12 percent of placebo-treated patients.

About Hyponatremia

Hyponatremia, a common electrolyte disorder in hospitals, occurs in as many as 6 million people in the United States or 15-20 percent of hospitalized p
'/>"/>

SOURCE Otsuka Pharmaceutical Co., Ltd.; Otsuka America Pharmaceutical, Inc.; Otsuka Pharmaceutical Development & Commercialization, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. FDA Approves New Roche West Nile Virus Blood Screening Test
3. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
4. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
5. FDA Approves SOMA(R) (carisoprodol) 250 mg
6. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
7. FDA approves expanded label for FluMist (influenza virus vaccine live, intranasal) to include childr
8. FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia
9. ABIH Approves Certification Credit for SSPC Training Courses
10. FDA Approves REALIZE(TM) Adjustable Gastric Band for Morbid Obesity
11. FDA Approves New Flu Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Florida (PRWEB) , ... August 31, 2015 , ... ... health insurance, announced today their new “ InstantQuote ” tool, which summarizes all ... and easy-to-understand format. The technology tool is designed to help India Network members ...
(Date:8/31/2015)... ... August 31, 2015 , ... Women’s ... , Starting September 1st they are offering pre and postnatal fitness ... "Healthy Body, Healthy Baby." , More information can be found at 248-601-6683. , ...
(Date:8/31/2015)... ... 31, 2015 , ... The Sundance Film Festival award winning documentary “Alive Inside” ... Inside” shadows a social worker who advocates for the use of music therapy for ... music to residents in health care centers who may have lost a spark in ...
(Date:8/31/2015)... NJ (PRWEB) , ... August 31, 2015 , ... Since ... quality, patient-oriented dental care. From the moment a patient arrives at the office, ... Steven Tuckman will work with each and every patient to create a complete dental ...
(Date:8/31/2015)... N.J. (PRWEB) , ... August 31, 2015 , ... ... participants—physicians, drug makers, diagnostic services, and others—to hold down costs? , In a ... chief executive officer of HealthReveal, presents the concept of “clinical efficacy,” which would ...
Breaking Medicine News(10 mins):Health News:India Network proudly launches the new InstantQuote tool to help choose right visitor health insurance with pre-existing conditions to US bound visitors 2Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2Health News:NJ Top Dentists Presents, Clifton Dental Associates! 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 2Health News:How “Clinical Efficacy” Can Rein in Healthcare Costs 3
... blood carry newly identified proteins that could be screened to ... at the Duke Cancer Institute. Building on current technologies ... was able to characterize these cells in a new way, ... move to other locations in the body. The circulating ...
... Leader of the Stem Cell and Developmental Biology at ... Dr Wa Xian at A*STAR,s Institute of Medical Biology ... School, the Brigham and Women,s Hospital in Boston, and ... finding that Barrett,s esophagus[1] work, published online in the ...
... Bdellovibrio against Salmonella in ... reduced the numbers of Salmonella bacteria and, importantly, ... The research was funded by the Biotechnology and Biological ... at The University of Nottingham, with Dr Robert Atterbury and ...
... -- The last quarter century has seen a such an explosion ... now struggle with the disease, a new British-American study reveals. ... diabetes has more than doubled, jumping from 153 million in 1980 ... diabetes in the United States is rising twice as fast as ...
... -- Lifestyle changes such as losing weight, drinking less alcohol ... in breast cancer cases across an entire population, according to ... risk factors. Although such models are often used to ... that women can,t change, such as a family history of ...
... FRIDAY, June 24 (HealthDay News) -- An exhausting emergency rescue ... lifeguard,s ability to carry out lifesaving CPR, according to a ... in doing cardiopulmonary resuscitation than were emergency medical personnel, the ... had 26 male and 14 female lifeguards perform CPR alone ...
Cached Medicine News:Health News:Duke team finds new clues to how cancer spreads 2Health News:Scientists identify a novel mechanism for evolution of highly aggressive cancers 2Health News:Scientists identify a novel mechanism for evolution of highly aggressive cancers 3Health News:Living antibiotic effective against Salmonella 2Health News:Diabetes on Upswing Worldwide 2Health News:Diabetes on Upswing Worldwide 3Health News:Lifestyle Changes Might Alter Breast Cancer Rates 2Health News:Exhausting Surf Rescues Don't Affect Lifeguards' CPR Skills 2
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, 2015 ... market for flow cytometry is experiencing a rise ... is the demand in underdeveloped nations to quantitate ... patients. Logo - http://photos.prnewswire.com/prnh/20150831/262206LOGO ... Sullivan, Analysis of the Global Flow Cytometry Market ...
(Date:8/31/2015)... -- The departments of Drug and Alcohol Programs (DDAP) and ... to raise awareness for International Overdose Awareness Day to ... and help more Pennsylvanians with substance use ... Building Bridges to Recovery initiative. ... a disease that is fully treatable, if given the ...
(Date:8/31/2015)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest ... Chairman & CEO, and Sean Whelan , CFO, will ... Hagerman and Mr. Whelan are scheduled to participate in the ... on Wednesday, September 9, 2015 at 1:45 PM ET. ... to participate in the Robert W. Baird 2015 Healthcare Conference ...
Breaking Medicine Technology:Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 2Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 3Clinical Applications of Flow Cytometry Instrumentation and Reagents are Transforming this Market with a High-Growth Path 4Pennsylvania Departments of Drug & Alcohol Programs and Health Kick-off Second Annual Building Bridges to Recovery Initiative 2Diplomat to Participate in Upcoming Investor Conferences 2
... Life Length, the world,s leading telomere testing and services ... have joined its Scientific Advisory Board ("SAB"). ... delighted to welcome these world-renowned telomere and telomerase experts ... global leadership.  Dr Chang is especially well known for ...
... Colo., March 6, 2012   Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products , today ... of best practices research, tools and metrics for patent ... again ranked Heska,s Science Strength in the top 50 ...
Cached Medicine Technology:Drs Sandy Chang and Kathleen Collins Join LIFE LENGTH®'s Scientific Advisory Board 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 2The Patent Board Ranks Heska's Science Strength in Biotechnology Industry Top 50 3
The KM-500's unique viewing and alignment window lets you observe the targeted eye from any distance. Two rechargeable batteries provide continuous uninterrupted use. Each battery provides 60 minutes...
Non-dissolvable Herrick Lacrimal Plugs provide long-term lacrimal occlusion through partial blockage of the horizontal canaliculus....
... Provides quick freezing and quick ... gas system - cleans the ... Lightweight probe tips have high ... Retinal Detachment, Glaucoma and Intra-vitreal ...
... instant defrosting by reversible flow of gas ... cycle automatically. Lightweight probe tips have high ... I/A. The surgeon can select either of ... Surgeon can have a selection of Irrigation, ...
Medicine Products: